跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DABIGATRAN ETEXILATO VIATRIS 75 MG CÁPSULAS DURAS EFG - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DABIGATRAN ETEXILATO VIATRIS 75 MG CÁPSULAS DURAS EFG
Approved
STANDARD
DABIGATRAN ETEXILATO VIATRIS 75 MG CÁPSULAS DURAS EFG
Viatris Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 26, 2024
Approval ID
c12ebb927c696a6f
Company
Viatris Limited
Type
Standard
Approval Details
Approval Id
c12ebb927c696a6f
Drug Cima Aemps Name
DABIGATRAN ETEXILATO VIATRIS 75 MG CÁPSULAS DURAS EFG
Register Number
89390
Holder Company Name
Viatris Limited
Marketing Company Name
Viatris Pharmaceuticals S.L.U.
Holder Company Detail Path
/organization/viatris-pharma-limited
Authorization Date
2024-02-26
Dosage Form
CÁPSULA DURA
Dose
75 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Viatris Limited
Company Detail Path
/organization/viatris-pharma-limited
Company Information
Pharmaceutical Company Name
VIATRIS PHARMA LIMITED
Country Name
Hong Kong, China
City Name
sha tin,country_hk
Address
Rm A7 8/F WAH WAI INDL BLDG
Active Ingredients
DABIGATRAN ETEXILATO MESILATO
86,475 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 26, 2024
Approval ID
c12ebb927c696a6f
Type
Standard
Back to CIMA-AEMPS Approvals
